Filing Details
- Accession Number:
- 0001127602-11-005902
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-16 20:27:02
- Reporting Period:
- 2011-02-15
- Filing Date:
- 2011-02-16
- Accepted Time:
- 2011-02-16 20:27:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
850693 | Allergan Inc | AGN | Pharmaceutical Preparations (2834) | 951622442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219890 | Alexander Robert Ingram | 2525 Dupont Drive Irvine CA 92612 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-02-15 | 10,800 | $73.61 | 14,564 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $73.5601 to $73.6501, inclusive. The reporting person undertakes to provide Allergan, Inc., any security holder of Allergan, Inc., or the staff of the Securities and Exchange Commission, upon request, the full information regarding the number of shares sold at each price within the range set forth in this footnote.